DIABETIC WOUND GEL- allantoin gel 
Lavior Pharma Inc

----------

Active Ingredients

Allantoin 0.5%.......................Skin Protectant

Purpose

Skin Protectant

Uses

Warnings

For external use only

When using this product

Stop use and ask a doctor if

Do not use

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

apply a thin layer 1 to 2 times daily, or as directed by a doctor

Other information

store at room temperature

Inactive Ingredients

Water/Aqua/Eau, Glycerin, Inula Viscosa Flower/Leaf/Stem Extract, Xanthan Gum, Phenoxyethanol, Propanediol, Tocopheryl Acetate, Ethylhexylglycerin, Sodium Gluconate, Citric Acid, Sodium Hyaluronate

Questions?

Call toll free 1844-474-2552 or visit www.lavior.com

Diabetic Wound Gel

DIABETIC WOUND GEL 
allantoin gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71521-036
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ALLANTOIN (UNII: 344S277G0Z) (ALLANTOIN - UNII:344S277G0Z) ALLANTOIN1 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
XANTHAN GUM (UNII: TTV12P4NEE)  
PROPANEDIOL (UNII: 5965N8W85T)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
SODIUM GLUCONATE (UNII: R6Q3791S76)  
DITTRICHIA VISCOSA WHOLE (UNII: 3SYW69FH88)  
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71521-036-5050 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product03/31/2021
2NDC:71521-036-1515 g in 1 TUBE; Type 0: Not a Combination Product03/17/2022
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01603/31/2021
Labeler - Lavior Pharma Inc (080685327)

Revised: 12/2023
Document Id: 0ce00714-9011-4e8e-e063-6394a90a2833
Set id: bdc55fbb-e391-0938-e053-2a95a90a1393
Version: 6
Effective Time: 20231219
 
Lavior Pharma Inc